Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.52
-0.2650-0.95%
Volume:10.45M
Turnover:287.58M
Market Cap:156.44B
PE:36.21
High:27.75
Open:27.75
Low:27.40
Close:27.78
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.96
T/O Rate:0.19%
Dividend:1.72
Dividend Rate:6.25%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.84
PE(LYR):20.17

Loading ...

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately

THOMSON REUTERS
·
Aug 28

Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance

THOMSON REUTERS
·
Aug 28

Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

TIPRANKS
·
Aug 28

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Reuters
·
Aug 27

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Pfizer Stock (PFE) Is a Buy despite Declining Revenues

TIPRANKS
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Pfizer Shows Signs of Stabilization as New Drug Revenue Surges 18%, Yet Patent Expirations Remain the Ultimate Hurdle

Stock News
·
Aug 24

Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

TIPRANKS
·
Aug 22

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case (PFE)?

Simply Wall St.
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

TIPRANKS
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

NYSE Most Active Issues

Dow Jones
·
Aug 21

Cboe data shows mixed options sentiment in Pfizer with shares down 1.5%

TIPRANKS
·
Aug 21

Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next

TIPRANKS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20